Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns

Barsan, V., Li, Y., Prabhu, S., Baggott, C., Nguyen, K., Pacenta, H., Phillips, C. L., Rossoff, J., Stefanski, H., Talano, J.-A., Moskop, A., Baumeister, S., Verneris, M. R., Myers, G. D., Karras, N. A., Cooper, S., Qayed, M., Hermiston, M., Satwani, P., … Schultz, L. M. (2023). Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine, 65, 102268. https://doi.org/10.1016/j.eclinm.2023.102268
Authors:
Valentin Barsan
Yimei Li
Vasant Chinnabhandar
Vasant Chinnabhandar
Khanh Nguyen
Holly L Pacenta
Christine L. Phillips
Holly L Pacenta
Heather Stefanski
Julie-An Talano
Amy Moskop
Susanne H.C. Baumeister
Holly L Pacenta
Holly L Pacenta
Nicole Karras
Stacy Cooper
Vasant Chinnabhandar
Holly L Pacenta
Vasant Chinnabhandar
Holly L Pacenta
Holly L Pacenta
Vanessa A. Fabrizio
Vasant Chinnabhandar
Holly L Pacenta
Holly L Pacenta
Crystal L. Mackall
Holly L Pacenta
Liora M. Schultz
Affiliated Authors:
Vasant Chinnabhandar
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
Gene Therapy Techniques and Applications (OpenAlex Topic)
Author Keywords:
car t cells
cd19 car t cells
commercial car
first relapse
immunotherapy
pediatric oncology
real-world analysis
tisagenlecleucel
elink
Publication Type:
Article
Unique ID:
10.1016/j.eclinm.2023.102268
PMID:
37954907
DOI:
10.1016/j.eclinm.2023.102268
Journal:
EClinicalMedicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: